Health Care Regulatory Diligence Considerations for Digital Health Transactions
This Briefing is brought to you by AHLA’s Health Information and Technology Practice Group.
- April 21, 2022
- Ming Chuang , Nossaman LLP
- Leeann Habte , Best Best & Krieger
- Ty Kayam , Microsoft
- Jennifer Kreick , Haynes and Boone LLP
- Claire Marblestone , Foley and Lardner LLP
- Adetoro Olugbemi , McDermott Will & Emery LLP
- Hannah Zaitlin , Foley and Lardner LLP
The digital health technology marketplace is booming, spawning a multitude of investment opportunities and a steadily growing volume of digital health transactions. Given the complex regulatory landscape surrounding these transactions, appropriate diligence is key to protecting investors. Digital health encompasses a broad array of technologies, including telehealth, mobile health applications, diagnostic tools and technology, electronic health records (EHR), wearables, remote patient monitoring, and many others. The variety of digital health technologies can make diligence challenging because of the varied health care regulations that can be implicated by different technologies. This Briefing outlines some of the potential health care regulatory considerations for a digital health transaction and includes tools, such as a sample diligence checklist, for these transactions.
ARTICLE TAGS
You must be logged in to access this content.